{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-032821","form_type":"8-K/A","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2024-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.008420+00:00","generated_at":"2026-06-04T15:44:45.938490+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ProKidney finalizes separation agreement with ex-CEO Bertram; $620K severance plus benefits","bullets":["Company pays $620K severance, bonus up to 60% of base salary for 2023 based on scorecard.","COBRA/Medicare premiums paid 100% through May 31, 2025; legal fees reimbursed up to $20K.","Vested stock options exercisable for 90 days after effective date; unvested equity forfeited.","Vested Class B ordinary shares remain subject to lockup until July 11, 2026 or regulatory milestone.","Standard release, non-disparagement, cooperation, and continuing obligations included."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-032821","json":"https://secwatch.observer/filing/0000950170-24-032821.json","markdown":"https://secwatch.observer/filing/0000950170-24-032821.md","text":"https://secwatch.observer/filing/0000950170-24-032821.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032821/0000950170-24-032821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032821/prok-20231110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T15:44:45.938490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"db2f2857b5","claim":"Dr. Bertram departed as ceo at PROKIDNEY CORP..","evidence_excerpt":"On March 13, 2024 (the “Effective Date”), the Company entered into a Separation Agreement (the “Separation Agreement”) with Dr. Bertram.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032821/0000950170-24-032821-index.htm","confidence":0.65,"family_label":"Executive change","details":[{"label":"Action","value":"separated"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}